Search

everythinglearnresearchcommunity

for

Search:↓

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A fungus ball in the lung can cause coughing up blood in SLE patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

New treatments for severe alopecia areata show promise but lack standard approval.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

NGF-modified hair follicle stem cells may help treat Alzheimer's by improving brain function and reducing harmful proteins.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Understanding embryologic layers improves skin disorder diagnosis and supports developing targeted therapies.